+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Dual-leg Rehabilitation Exoskeleton Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6080118
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

An emerging era in rehabilitation technology is redefining outcomes for individuals with lower limb impairments. Dual-leg exoskeletons are advancing from experimental prototypes to viable therapeutic solutions, offering enhanced mobility, adaptive support, and personalized rehabilitation protocols. This executive summary introduces the latest innovations, explores the transformative drivers reshaping the market, and highlights strategic insights critical for stakeholders. The convergence of robotics, artificial intelligence, and materials science is empowering clinicians to deliver more effective, data-driven interventions while enabling patients to regain independence faster.

As healthcare systems worldwide confront rising demands from aging populations and chronic neurological conditions, the exoskeleton sector is poised for rapid growth. Investors and industry leaders must navigate an evolving regulatory landscape, shifting reimbursement frameworks, and complex supply chain dynamics. This introduction sets the stage for a deep dive into the key market forces, segmentation nuances, regional variations, and competitive benchmarks that will define success. By understanding these foundational elements, decision-makers can align product development, go-to-market strategies, and partnerships to capture untapped opportunities and drive sustained value.

Transformative Shifts in the Rehabilitation Exoskeleton Landscape

Over the past decade, rehabilitation robotics has shifted from laboratory curiosities to clinically validated interventions. Technological breakthroughs in sensor miniaturization, computational power, and machine learning have enabled exoskeletons to deliver adaptive assistance in real time. Concurrently, a growing body of clinical evidence underscores the efficacy of dual-leg systems for stroke survivors, spinal cord injury patients, and individuals with degenerative neurological disorders.

Demographic trends are amplifying demand, as aging populations in North America, Europe, and Asia-Pacific face rising incidences of arthritis, osteoporosis, and joint replacements. Payers and providers are responding by prioritizing value-based care models that emphasize improved functional outcomes and reduced long-term costs. This paradigm shift is fueling partnerships between robotics firms, rehabilitation centers, and academic medical institutions.

Moreover, advancements in materials science have produced lighter, stronger alloys and biodegradable composites, driving down device weight without sacrificing durability. Virtual reality and immersive gaming integrations are redefining patient engagement, while remote monitoring via IoT-enabled platforms is expanding access to home-based therapy. Together, these transformative dynamics are catalyzing a new era in mobility restoration and setting the stage for accelerated market expansion.

Cumulative Impact of United States Tariffs 2025

In 2025, the United States imposed revised tariffs on key robotic components and advanced materials, directly affecting the cost structure of exoskeleton manufacturing. Components subject to higher import duties include precision actuators, microprocessors, and specialized carbon fiber modules sourced from Asia-Pacific and Europe. These adjustments have led to a temporary increase in production costs, prompting suppliers to reevaluate sourcing strategies and negotiate volume discounts with domestic and overseas vendors.

Manufacturers are responding by optimizing supply chains through regional manufacturing hubs and forging strategic alliances with local material providers. Some firms have accelerated investments in in-house component development to mitigate exposure to tariff fluctuations. Meanwhile, end users-hospitals and rehabilitation centers-are absorbing a portion of the cost increase through bundled service agreements, while home-use device providers are introducing modular upgrade paths to spread expenses over time.

Regulatory bodies are collaborating with industry associations to streamline approval pathways for modified designs that utilize tariff-exempt materials. This regulatory flexibility is designed to sustain innovation momentum despite trade headwinds. Ultimately, although the 2025 tariffs have introduced transitional challenges, proactive supply chain optimization and adaptive pricing strategies are positioning leading exoskeleton developers to maintain competitive advantage.

Key Segmentation Insights

When examining rehabilitation needs, the market divides according to injury type into two major categories. Devices targeting neurological disorders account for a significant share, especially systems designed for multiple sclerosis, Parkinson’s disease, spinal cord injuries, and stroke rehabilitation. Orthopedic conditions represent another critical segment, with applications focused on arthritis management, bone fracture recovery, and joint replacement support.

Diverse end users drive demand across home use, hospital settings, and specialized rehabilitation centers. In home environments, manufacturers cater to long-term therapy regimens, portable device configurations, and short-term post-operative recovery protocols, balancing usability with clinical efficacy. Hospitals require scalable systems that integrate seamlessly into inpatient workflows, while rehabilitation centers seek modular platforms capable of multi-patient customization.

Assistance modality also shapes product design, ranging from active assistance systems providing full or partial actuation to passive devices offering balance support or weight-bearing relief. Technology integration enhances these capabilities through artificial intelligence-powered adaptive control systems, predictive algorithms, IoT-enabled data monitoring, and remote adjustment functionalities. Virtual reality modules further enrich therapy through immersive gaming experiences and therapeutic training simulations.

Material composition influences durability, patient comfort, and environmental impact. Biodegradable plant-based polymers appeal to eco-conscious buyers, whereas carbon fiber composites deliver high strength-to-weight ratios. Lightweight aluminum alloys offer cost-effective structural integrity. Consumer age profiles-from pediatric users aged 3 to 17, adults between 18 and 65, to geriatrics over 65-demand ergonomic customization and safety features. Finally, price positioning spans economy, mid-range, and premium tiers, allowing providers to align offerings with reimbursement policies and patient budgets.

Key Regional Insights

In the Americas, robust healthcare infrastructure and well-established reimbursement frameworks underpin significant adoption of dual-leg exoskeletons. North American providers are pioneering value-based contracting, and U.S. hospitals are integrating robotic gait training into standard stroke and spinal injury protocols. Canada’s publicly funded system is exploring pilot programs for home-based rehabilitation, incentivizing manufacturers to offer remote monitoring packages.

The Europe, Middle East & Africa region combines advanced clinical facilities in Western Europe with emerging markets investing in rehabilitation technology. Germany, France, and the U.K. lead in clinical research partnerships, while Middle Eastern nations are allocating resources to diversify healthcare services. South Africa and Gulf Cooperation Council states are integrating exoskeletons into veteran rehabilitation and sports injury centers.

Asia-Pacific presents a heterogeneous landscape, with Japan and South Korea at the forefront of robotic innovation and China ramping up local production capabilities. India is focusing on cost-effective devices to address large unmet needs, while Australia leverages public-private collaborations for rural deployment. Regional free-trade agreements are gradually reducing tariffs on medical robotics components, fostering supply chain resilience and market expansion across the Asia-Pacific bloc.

Key Companies Insights

Competition within the dual-leg exoskeleton market is intensifying, driven by both established players and agile startups. Leading specialists such as Bionik Laboratories Corp. and BioXtreme are differentiating through clinical outcome studies and strategic hospital partnerships. Cyberdyne Inc. and Ekso Bionics Holdings, Inc. continue to innovate actuator designs, while Fourier Intelligence Co., Ltd. emphasizes modular platforms with rapid customization capabilities.

Emerging robotics pioneers like Gogoa Mobility Robots and MedEXO Robotics focus on affordability for developing markets, and Hocoma AG leverages its global rehabilitation network to integrate virtual reality therapy modules. Marsi Bionics and Myomo, Inc. are expanding their product portfolios to include pediatric applications, whereas Ottobock SE & Co. KGaA and Parker Hannifin Corporation capitalize on extensive distribution channels and after-sales service infrastructures.

ReWalk Robotics Ltd. and Rex Bionics Ltd. champion patient independence through wearable designs optimized for community mobility. SuitX distinguishes itself by offering open-architecture software ecosystems, empowering third-party developers to create bespoke therapeutic applications. Across this competitive landscape, firms are converging on partnerships with academic centers, payers, and regulatory bodies to accelerate adoption and scale manufacturing economies.

Actionable Recommendations for Industry Leaders

First, companies should prioritize research collaborations with leading rehabilitation institutions to validate clinical efficacy and secure endorsement from key opinion leaders. Second, supply chain diversification must be accelerated by establishing regional assembly hubs and forging alliances with tariff-exempt component suppliers. Third, integrating advanced analytics and remote monitoring features will enhance value propositions under evolving value-based care models.

Fourth, flexible pricing and leasing options can broaden market reach, especially for home-use segments seeking budget-friendly solutions. Fifth, firms should pursue modular hardware architectures that support easy upgrades, minimizing capital expenditure risks for buyers. Sixth, expansion into emerging markets requires culturally tailored training programs and localized regulatory support to overcome adoption barriers.

Seventh, sustainability commitments through biodegradable materials and recyclable alloys can bolster corporate responsibility credentials. Eighth, device manufacturers must invest in cybersecurity protocols to safeguard patient data transmitted via IoT platforms. Finally, strategic alliances with payers and governmental agencies will be crucial to securing reimbursement pathways and public funding for large-scale deployment projects.

Conclusion

Dual-leg rehabilitation exoskeletons represent a transformative frontier in restoring mobility and independence for patients worldwide. The blend of robotics, AI, immersive therapies, and lightweight materials is creating powerful tools that address complex rehabilitation needs more effectively than ever before. Despite challenges posed by trade policies, regulatory intricacies, and competitive pressures, forward-thinking companies have clear pathways to accelerate adoption, optimize cost structures, and demonstrate compelling clinical outcomes.

By embracing supply chain agility, evidence-based collaborations, and patient-centric design, stakeholders can navigate market complexities and position themselves as leaders in an expanding ecosystem. As regional markets mature and reimbursement models evolve, organizations that balance innovation with operational discipline will capture the greatest share of this high-impact segment. The journey ahead demands strategic foresight, cross-sector partnerships, and relentless focus on delivering tangible patient benefits.

Market Segmentation & Coverage

This research report categorizes the Dual-leg Rehabilitation Exoskeleton Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Neurological Disorders
    • Multiple Sclerosis
    • Parkinson's Disease
    • Spinal Cord Injuries
    • Stroke Rehabilitation
  • Orthopedic Conditions
    • Arthritis
    • Bone Fractures
    • Joint Replacements
  • Home Use
    • Long-term Use
    • Portable Devices
    • Short-term Use
  • Hospitals
  • Rehabilitation Centers
  • Active Assistance
    • Full Assistance
    • Partial Assistance
  • Passive Assistance
    • Balance Support
    • Weight-Supporting
  • Artificial Intelligence Integration
    • Adaptive Control Systems
    • Predictive Algorithms
  • IoT Capabilities
    • Data Monitoring
    • Remote Adjustments
  • Virtual Reality Integration
    • Immersive Gaming
    • Therapeutic Training
  • Biodegradable Materials
    • Plant-Based Polymers
  • Composite Materials
    • Carbon Fiber
  • Lightweight Alloys
    • Aluminum Alloys
  • Adult
    • Age 18-45
    • Age 46-65
  • Geriatric
    • Age 65 and Above
    • Age 75 and Above
  • Pediatric
    • Age 13-17
    • Age 3-12
  • Economy
  • Mid-range
  • Premium

This research report categorizes the Dual-leg Rehabilitation Exoskeleton Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Dual-leg Rehabilitation Exoskeleton Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Bionik Laboratories Corp.
  • BioXtreme
  • Cyberdyne Inc.
  • Ekso Bionics Holdings, Inc.
  • Fourier Intelligence Co., Ltd.
  • Gogoa Mobility Robots
  • Hocoma AG
  • Marsi Bionics
  • MedEXO Robotics
  • Myomo, Inc.
  • Ottobock SE & Co. KGaA
  • Parker Hannifin Corporation
  • ReWalk Robotics Ltd.
  • Rex Bionics Ltd.
  • SuitX

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Dual-leg Rehabilitation Exoskeleton Market, by Injury Type
8.1. Introduction
8.2. Neurological Disorders
8.2.1. Multiple Sclerosis
8.2.2. Parkinson's Disease
8.2.3. Spinal Cord Injuries
8.2.4. Stroke Rehabilitation
8.3. Orthopedic Conditions
8.3.1. Arthritis
8.3.2. Bone Fractures
8.3.3. Joint Replacements
9. Dual-leg Rehabilitation Exoskeleton Market, by End User
9.1. Introduction
9.2. Home Use
9.2.1. Long-term Use
9.2.2. Portable Devices
9.2.3. Short-term Use
9.3. Hospitals
9.4. Rehabilitation Centers
10. Dual-leg Rehabilitation Exoskeleton Market, by Type Of Assistance
10.1. Introduction
10.2. Active Assistance
10.2.1. Full Assistance
10.2.2. Partial Assistance
10.3. Passive Assistance
10.3.1. Balance Support
10.3.2. Weight-Supporting
11. Dual-leg Rehabilitation Exoskeleton Market, by Technology Integration
11.1. Introduction
11.2. Artificial Intelligence Integration
11.2.1. Adaptive Control Systems
11.2.2. Predictive Algorithms
11.3. IoT Capabilities
11.3.1. Data Monitoring
11.3.2. Remote Adjustments
11.4. Virtual Reality Integration
11.4.1. Immersive Gaming
11.4.2. Therapeutic Training
12. Dual-leg Rehabilitation Exoskeleton Market, by Product Material
12.1. Introduction
12.2. Biodegradable Materials
12.2.1. Plant-Based Polymers
12.3. Composite Materials
12.3.1. Carbon Fiber
12.4. Lightweight Alloys
12.4.1. Aluminum Alloys
13. Dual-leg Rehabilitation Exoskeleton Market, by Consumer Age
13.1. Introduction
13.2. Adult
13.2.1. Age 18-45
13.2.2. Age 46-65
13.3. Geriatric
13.3.1. Age 65 and Above
13.3.2. Age 75 and Above
13.4. Pediatric
13.4.1. Age 13-17
13.4.2. Age 3-12
14. Dual-leg Rehabilitation Exoskeleton Market, by Price Range
14.1. Introduction
14.2. Economy
14.3. Mid-range
14.4. Premium
15. Americas Dual-leg Rehabilitation Exoskeleton Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Dual-leg Rehabilitation Exoskeleton Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Dual-leg Rehabilitation Exoskeleton Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Bionik Laboratories Corp.
18.3.2. BioXtreme
18.3.3. Cyberdyne Inc.
18.3.4. Ekso Bionics Holdings, Inc.
18.3.5. Fourier Intelligence Co., Ltd.
18.3.6. Gogoa Mobility Robots
18.3.7. Hocoma AG
18.3.8. Marsi Bionics
18.3.9. MedEXO Robotics
18.3.10. Myomo, Inc.
18.3.11. Ottobock SE & Co. KGaA
18.3.12. Parker Hannifin Corporation
18.3.13. ReWalk Robotics Ltd.
18.3.14. Rex Bionics Ltd.
18.3.15. SuitX
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. DUAL-LEG REHABILITATION EXOSKELETON MARKET MULTI-CURRENCY
FIGURE 2. DUAL-LEG REHABILITATION EXOSKELETON MARKET MULTI-LANGUAGE
FIGURE 3. DUAL-LEG REHABILITATION EXOSKELETON MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY INJURY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY INJURY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY TYPE OF ASSISTANCE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY TYPE OF ASSISTANCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PRODUCT MATERIAL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PRODUCT MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY CONSUMER AGE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY CONSUMER AGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PRICE RANGE, 2024 VS 2030 (%)
FIGURE 20. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PRICE RANGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. DUAL-LEG REHABILITATION EXOSKELETON MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. DUAL-LEG REHABILITATION EXOSKELETON MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DUAL-LEG REHABILITATION EXOSKELETON MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY SPINAL CORD INJURIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY STROKE REHABILITATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ORTHOPEDIC CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY BONE FRACTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY JOINT REPLACEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ORTHOPEDIC CONDITIONS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY HOME USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY LONG-TERM USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PORTABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY SHORT-TERM USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY HOME USE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY TYPE OF ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ACTIVE ASSISTANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY FULL ASSISTANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PARTIAL ASSISTANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ACTIVE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PASSIVE ASSISTANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY BALANCE SUPPORT, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY WEIGHT-SUPPORTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PASSIVE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ARTIFICIAL INTELLIGENCE INTEGRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ADAPTIVE CONTROL SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PREDICTIVE ALGORITHMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ARTIFICIAL INTELLIGENCE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY IOT CAPABILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY DATA MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY REMOTE ADJUSTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY IOT CAPABILITIES, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY VIRTUAL REALITY INTEGRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY IMMERSIVE GAMING, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY THERAPEUTIC TRAINING, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY VIRTUAL REALITY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PRODUCT MATERIAL, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY BIODEGRADABLE MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PLANT-BASED POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY BIODEGRADABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY COMPOSITE MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY CARBON FIBER, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY LIGHTWEIGHT ALLOYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ALUMINUM ALLOYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY LIGHTWEIGHT ALLOYS, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY CONSUMER AGE, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY AGE 18-45, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY AGE 46-65, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY AGE 65 AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY AGE 75 AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY AGE 13-17, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY AGE 3-12, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ECONOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY MID-RANGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PREMIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ORTHOPEDIC CONDITIONS, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY HOME USE, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY TYPE OF ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ACTIVE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PASSIVE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ARTIFICIAL INTELLIGENCE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY IOT CAPABILITIES, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY VIRTUAL REALITY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PRODUCT MATERIAL, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY BIODEGRADABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY LIGHTWEIGHT ALLOYS, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY CONSUMER AGE, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ORTHOPEDIC CONDITIONS, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY HOME USE, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY TYPE OF ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ACTIVE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PASSIVE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ARTIFICIAL INTELLIGENCE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY IOT CAPABILITIES, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY VIRTUAL REALITY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PRODUCT MATERIAL, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY BIODEGRADABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY LIGHTWEIGHT ALLOYS, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY CONSUMER AGE, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ORTHOPEDIC CONDITIONS, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY HOME USE, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY TYPE OF ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ACTIVE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PASSIVE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ARTIFICIAL INTELLIGENCE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY IOT CAPABILITIES, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY VIRTUAL REALITY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PRODUCT MATERIAL, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY BIODEGRADABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY LIGHTWEIGHT ALLOYS, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY CONSUMER AGE, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 139. CANADA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 140. CANADA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 141. CANADA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ORTHOPEDIC CONDITIONS, 2018-2030 (USD MILLION)
TABLE 142. CANADA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. CANADA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY HOME USE, 2018-2030 (USD MILLION)
TABLE 144. CANADA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY TYPE OF ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 145. CANADA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ACTIVE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 146. CANADA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PASSIVE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 147. CANADA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 148. CANADA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ARTIFICIAL INTELLIGENCE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 149. CANADA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY IOT CAPABILITIES, 2018-2030 (USD MILLION)
TABLE 150. CANADA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY VIRTUAL REALITY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 151. CANADA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PRODUCT MATERIAL, 2018-2030 (USD MILLION)
TABLE 152. CANADA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY BIODEGRADABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 153. CANADA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 154. CANADA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY LIGHTWEIGHT ALLOYS, 2018-2030 (USD MILLION)
TABLE 155. CANADA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY CONSUMER AGE, 2018-2030 (USD MILLION)
TABLE 156. CANADA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 157. CANADA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 158. CANADA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 159. CANADA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 160. MEXICO DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 161. MEXICO DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 162. MEXICO DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ORTHOPEDIC CONDITIONS, 2018-2030 (USD MILLION)
TABLE 163. MEXICO DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. MEXICO DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY HOME USE, 2018-2030 (USD MILLION)
TABLE 165. MEXICO DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY TYPE OF ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 166. MEXICO DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ACTIVE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 167. MEXICO DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PASSIVE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 168. MEXICO DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 169. MEXICO DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ARTIFICIAL INTELLIGENCE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 170. MEXICO DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY IOT CAPABILITIES, 2018-2030 (USD MILLION)
TABLE 171. MEXICO DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY VIRTUAL REALITY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 172. MEXICO DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PRODUCT MATERIAL, 2018-2030 (USD MILLION)
TABLE 173. MEXICO DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY BIODEGRADABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 174. MEXICO DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 175. MEXICO DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY LIGHTWEIGHT ALLOYS, 2018-2030 (USD MILLION)
TABLE 176. MEXICO DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY CONSUMER AGE, 2018-2030 (USD MILLION)
TABLE 177. MEXICO DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 178. MEXICO DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 179. MEXICO DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 180. MEXICO DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 181. UNITED STATES DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 182. UNITED STATES DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 183. UNITED STATES DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ORTHOPEDIC CONDITIONS, 2018-2030 (USD MILLION)
TABLE 184. UNITED STATES DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. UNITED STATES DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY HOME USE, 2018-2030 (USD MILLION)
TABLE 186. UNITED STATES DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY TYPE OF ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 187. UNITED STATES DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ACTIVE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 188. UNITED STATES DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PASSIVE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 189. UNITED STATES DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 190. UNITED STATES DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ARTIFICIAL INTELLIGENCE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 191. UNITED STATES DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY IOT CAPABILITIES, 2018-2030 (USD MILLION)
TABLE 192. UNITED STATES DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY VIRTUAL REALITY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 193. UNITED STATES DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PRODUCT MATERIAL, 2018-2030 (USD MILLION)
TABLE 194. UNITED STATES DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY BIODEGRADABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 195. UNITED STATES DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 196. UNITED STATES DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY LIGHTWEIGHT ALLOYS, 2018-2030 (USD MILLION)
TABLE 197. UNITED STATES DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY CONSUMER AGE, 2018-2030 (USD MILLION)
TABLE 198. UNITED STATES DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 199. UNITED STATES DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 200. UNITED STATES DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 201. UNITED STATES DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 202. UNITED STATES DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ORTHOPEDIC CONDITIONS, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY HOME USE, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY TYPE OF ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ACTIVE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PASSIVE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 212. ASIA-PACIFIC DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ARTIFICIAL INTELLIGENCE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 213. ASIA-PACIFIC DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY IOT CAPABILITIES, 2018-2030 (USD MILLION)
TABLE 214. ASIA-PACIFIC DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY VIRTUAL REALITY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 215. ASIA-PACIFIC DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PRODUCT MATERIAL, 2018-2030 (USD MILLION)
TABLE 216. ASIA-PACIFIC DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY BIODEGRADABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 217. ASIA-PACIFIC DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 218. ASIA-PACIFIC DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY LIGHTWEIGHT ALLOYS, 2018-2030 (USD MILLION)
TABLE 219. ASIA-PACIFIC DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY CONSUMER AGE, 2018-2030 (USD MILLION)
TABLE 220. ASIA-PACIFIC DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 221. ASIA-PACIFIC DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 222. ASIA-PACIFIC DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 223. ASIA-PACIFIC DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 224. ASIA-PACIFIC DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 225. AUSTRALIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ORTHOPEDIC CONDITIONS, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY HOME USE, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY TYPE OF ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ACTIVE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PASSIVE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 233. AUSTRALIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 234. AUSTRALIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ARTIFICIAL INTELLIGENCE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 235. AUSTRALIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY IOT CAPABILITIES, 2018-2030 (USD MILLION)
TABLE 236. AUSTRALIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY VIRTUAL REALITY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 237. AUSTRALIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PRODUCT MATERIAL, 2018-2030 (USD MILLION)
TABLE 238. AUSTRALIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY BIODEGRADABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 239. AUSTRALIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 240. AUSTRALIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY LIGHTWEIGHT ALLOYS, 2018-2030 (USD MILLION)
TABLE 241. AUSTRALIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY CONSUMER AGE, 2018-2030 (USD MILLION)
TABLE 242. AUSTRALIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 243. AUSTRALIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 244. AUSTRALIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 245. AUSTRALIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 246. CHINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 247. CHINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 248. CHINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ORTHOPEDIC CONDITIONS, 2018-2030 (USD MILLION)
TABLE 249. CHINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. CHINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY HOME USE, 2018-2030 (USD MILLION)
TABLE 251. CHINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY TYPE OF ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 252. CHINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ACTIVE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 253. CHINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PASSIVE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 254. CHINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 255. CHINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ARTIFICIAL INTELLIGENCE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 256. CHINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY IOT CAPABILITIES, 2018-2030 (USD MILLION)
TABLE 257. CHINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY VIRTUAL REALITY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 258. CHINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PRODUCT MATERIAL, 2018-2030 (USD MILLION)
TABLE 259. CHINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY BIODEGRADABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 260. CHINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 261. CHINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY LIGHTWEIGHT ALLOYS, 2018-2030 (USD MILLION)
TABLE 262. CHINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY CONSUMER AGE, 2018-2030 (USD MILLION)
TABLE 263. CHINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 264. CHINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 265. CHINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 266. CHINA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 267. INDIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 268. INDIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 269. INDIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ORTHOPEDIC CONDITIONS, 2018-2030 (USD MILLION)
TABLE 270. INDIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. INDIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY HOME USE, 2018-2030 (USD MILLION)
TABLE 272. INDIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY TYPE OF ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 273. INDIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ACTIVE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 274. INDIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PASSIVE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 275. INDIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 276. INDIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ARTIFICIAL INTELLIGENCE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 277. INDIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY IOT CAPABILITIES, 2018-2030 (USD MILLION)
TABLE 278. INDIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY VIRTUAL REALITY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 279. INDIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY PRODUCT MATERIAL, 2018-2030 (USD MILLION)
TABLE 280. INDIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY BIODEGRADABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 281. INDIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 282. INDIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY LIGHTWEIGHT ALLOYS, 2018-2030 (USD MILLION)
TABLE 283. INDIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY CONSUMER AGE, 2018-2030 (USD MILLION)
TABLE 284. INDIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 285. INDIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 286. INDIA DUAL-LEG REHABILITATION EXOSKELETON MARKET SIZE, BY

Companies Mentioned

  • Bionik Laboratories Corp.
  • BioXtreme
  • Cyberdyne Inc.
  • Ekso Bionics Holdings, Inc.
  • Fourier Intelligence Co., Ltd.
  • Gogoa Mobility Robots
  • Hocoma AG
  • Marsi Bionics
  • MedEXO Robotics
  • Myomo, Inc.
  • Ottobock SE & Co. KGaA
  • Parker Hannifin Corporation
  • ReWalk Robotics Ltd.
  • Rex Bionics Ltd.
  • SuitX

Methodology

Loading
LOADING...